How to use the speech recognition tool?
NCT03314207
XOLARIS
Natural history of the progression of X-linked retinitis pigmentosa.
Type: Observational
Status of the trial: Active, Recruiting
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2018-01-01
- Closing Date: 2020-01-01
Criteria
Inclusion: Visual Acuity from20/200 to 20/20, Molecular confirmed mutation in RPGR
Children: No
Adults: No
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)